| |
| |
| Exchange: |
Over The Counter |
| Security
Type: |
Common |
| Shares
Out: |
570,750,000 |
| Market
Cap: |
78.48(M) |
| Last
Volume: |
667,553 |
Avg
Vol: |
3,188,039 |
| 52
Week Range: |
$0.131 - $0.3 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CytoDyn is a clinical-stage biotechnology company focused on the clinical development of treatments for multiple therapeutic indications based on its product candidate, leronlimab, a humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor. Leronlimab is being investigated as a viral entry inhibitor for Human Immunodeficiency Virus. Leronlimab is also being studied in oncology, as well as other therapeutic indications, including coronavirus disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Pourhassan Nader |
Chief Operating Officer |
• – – |
2009-03-01 |
5 |
GD |
$0.00 |
$0 |
D/D |
80,900 |
249,100 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2009-02-24 |
5 |
B |
$0.41 |
$41 |
I/I |
100 |
263,674 |
|
- |
|
| Utek Corp |
10% Owner |
– – • |
2009-02-02 |
4 |
S |
$0.08 |
$171,360 |
D/D |
(2,040,000) |
0 |
|
- |
|
| Van Ness Kenneth |
10% Owner |
– – • |
2009-01-12 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
2,040,000 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2009-01-07 |
5 |
B |
$0.35 |
$35 |
I/I |
100 |
263,574 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2009-01-07 |
5 |
S |
$0.30 |
$3,000 |
I/I |
(10,000) |
263,474 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2008-12-31 |
5 |
B |
$0.42 |
$42 |
I/I |
100 |
273,474 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2008-12-31 |
5 |
S |
$0.30 |
$1,500 |
I/I |
(5,000) |
273,374 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2008-12-30 |
5 |
B |
$0.42 |
$84 |
I/I |
200 |
278,374 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2008-12-30 |
5 |
S |
$0.30 |
$4,740 |
I/I |
(15,800) |
278,174 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2008-12-18 |
5 |
B |
$0.47 |
$47 |
I/I |
100 |
293,974 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2008-12-18 |
5 |
S |
$0.40 |
$4,000 |
I/I |
(10,000) |
293,874 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2008-12-10 |
5 |
B |
$0.47 |
$47 |
I/I |
100 |
303,874 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2008-12-10 |
5 |
S |
$0.31 |
$1,850 |
I/I |
(6,000) |
303,774 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2008-12-02 |
5 |
S |
$0.37 |
$1,850 |
I/I |
(5,000) |
309,774 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2008-11-24 |
5 |
B |
$0.49 |
$49 |
I/I |
100 |
314,774 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2008-11-21 |
5 |
B |
$0.49 |
$49 |
I/I |
100 |
314,674 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2008-11-21 |
5 |
S |
$0.37 |
$740 |
I/I |
(2,000) |
314,574 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2008-11-14 |
5 |
B |
$0.47 |
$47 |
I/I |
100 |
316,574 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2008-11-13 |
5 |
S |
$0.40 |
$2,000 |
I/I |
(5,000) |
316,474 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2008-11-12 |
5 |
S |
$0.40 |
$2,400 |
I/I |
(6,000) |
321,474 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2008-11-07 |
5 |
B |
$0.49 |
$49 |
I/I |
100 |
327,474 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2008-11-07 |
5 |
S |
$0.30 |
$5,100 |
I/I |
(17,000) |
327,374 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2008-11-06 |
5 |
S |
$0.30 |
$900 |
I/I |
(3,000) |
344,374 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2008-11-05 |
5 |
S |
$0.35 |
$10,500 |
I/I |
(30,000) |
347,374 |
|
- |
|
381 Records found
|
|
Page 13 of 16 |
|
|
